TheraNano LLC

Newton, MA · Medtech · Private

INCeRT spacers—implantable brachytherapy devices loaded with Docetaxel for local chemoradiation therapy of prostate cancer

Grants
$4.9M
7 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$300K
1 award · Health and Human S
#419 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Quantitative Non-Invasive Brain Imaging using Magnetic Nanoparticles$225,211
Federal grantDepartment of Health and Human Services · Phase I · Quantitative Non Invasive Brain Imaging using Magnetic Nanoparticles$225,211
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Drug-eluting Brachytherapy Implants for Chemo-radiation Therapy$225,000
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Drug eluting Brachytherapy Implants for Chemo radiation Therapy$225,000
Federal contractDepartment of Health and Human Services · Igf::ot::igf SBIR Topic 374, Phase I:sustained Delivery Of Parp Inhibitors For Cancer Chemoprevention$300,000
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Drug-eluting Brachytherapy Implants for Chemo-radiation Therapy$2,000,000
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Drug-eluting Brachytherapy Implants for Chemo-radiation Therapy$1,007,156
Federal grantDepartment of Health and Human Services · Phase II · Drug-eluting Brachytherapy Implants for Chemo-radiation Therapy$992,844
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
416INSIGHTEC LTD$309K$300M
417AEROPHASE, INC.$304K—
418CORGENIX MEDICAL CORPORATION$301K—
419TheraNano LLC$300K—
420LIFETIME OMICS, INC.$300K—
421ESPER BIOSCIENCES INC$300K—
422DARWIN BIOSCIENCES, INC.$299K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.